|
2023
|
Invention
|
Population of transfected immune cells and method for their production. The invention provides an... |
|
2022
|
Invention
|
Covid-19 therapy. The present invention provides a method of a treatment or prophylaxis of a SARS... |
|
2021
|
Invention
|
Treatment of sars-cov-2 infection with a combination of targets. The invention provides a combina... |
|
|
Invention
|
Methods for treatment of virus. Provided herein are methods for treating or preventing infection ... |
|
2017
|
Invention
|
Treatment of inflammatory illnesses with ace2.
The present invention relates to ACE2 for the the... |
|
2016
|
Invention
|
Bicyclic tetrahydrothiazepine derivatives useful for the treatment of neoplastic and/or infectiou... |
|
2015
|
Invention
|
Sirna against cbl-b and optionally il-2 and il-12 for use in the treatment of cancer.
The invent... |
|
|
G/S
|
Pharmaceutical and veterinary preparations; diagnostic
preparations for medical purposes; sanita... |
|
|
G/S
|
Pharmaceutical and veterinary preparations for the treatment of cancer. |
|
2014
|
Invention
|
Preparations and methods for treating a gd2 positive cancer. The present invention relates to pre... |
|
|
Invention
|
Modified ace2 polypeptides. The present invention relates to modified angiotensin converting enzy... |
|
2013
|
Invention
|
Method for treating a gd2 positive cancer. The present invention relates to preparations an... |
|
|
Invention
|
Ace2 polypeptide.
The present invention relates to recombinant ACE2 polypeptide, where the ACE2 ... |
|
2012
|
Invention
|
Compositions for preventing or treating adverse reactions of egfr inhibition.
The invention disc... |
|
|
Invention
|
Compositions for preventing or treating adverse reactions of egfr inhibition. The invention discl... |
|
|
Invention
|
Method for treating a gd2 positive cancer. The present invention relates to a method for treating... |
|
|
Invention
|
Ace2 activation for treatment of heart, lung and kidney disease and hypertension. ACE2 activating... |
|
2011
|
Invention
|
Sirna against cbl-b and optionally il2 und il12 for use in the treatment of cancer. The invention... |
|
|
Invention
|
Sirna against cbl-b and optionally il-2 and il-12 for use in the treatment of cancer. The inventi... |
|
2010
|
Invention
|
Method for determining the cbl-b expression.
The present invention relates to methods of determi... |
|
|
Invention
|
Method for determining the cbl-b expression. The present invention relates to methods of d... |
|
|
Invention
|
Method for determining the cbl-b expression. The present invention relates to methods for determi... |
|
2009
|
Invention
|
Treatment of tumours. The invention relates to the use of a polypeptide having an angiotens... |
|
|
Invention
|
Treatment of tumors. The invention relates to the use of a polypeptide having an angiotensin conv... |
|
2008
|
Invention
|
Treatment of fibroses and liver disorders. The present invention relates to ACE2 for the t... |
|
|
Invention
|
Treatment of fibroses and liver disorders. The present invention relates to ACE2 for the therapeu... |
|
|
Invention
|
Treatment of inflammatory illnesses with ace2. The present invention relates to ACE2 for t... |
|
|
Invention
|
Treatment of inflammatory illnesses with ace2. The present invention relates to ACE2 for the ther... |
|
|
Invention
|
Method for increasing immunoreactivity. The invention relates to an in vitro or ex vivo method fo... |
|
|
Invention
|
Method for increasing immunoreactivity. The invention relates to an in vitro or ex vivo met... |
|
|
Invention
|
Ace2 polypeptide. The present invention relates to recombinant ACE2 polypeptide, where the ACE2 p... |
|
|
Invention
|
Ace2 polypeptide. The present invention relates to recombinant ACE2 polypeptide, where the ... |
|
2003
|
Invention
|
Ace2 activation for treatment of heart, lung and kidney disease and hypertension. The invention r... |
